Surgery Prevails as Initial Therapy for mRCC
Patients with untreated metastatic renal cell carcinoma (mRCC) had significantly better survival with surgery rather than targeted therapy as the initial treatment, a retrospective review of 15,000 patients showed.08/17/2018
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Renal Cell Carcinoma | Urology & Nephrology